Status:
RECRUITING
The Glaucoma and Retinopathy Screening Study
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Glaucoma
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field te...
Detailed Description
Study Overview: This study is a prospective, interventional clinical trial designed to evaluate the effectiveness of an artificial intelligence (AI)-based screening program within community health set...
Eligibility Criteria
Inclusion
- Individuals with diabetes undergoing AI-based screening for diabetic retinopathy using the LumineticsCore (Digital Diagnostics) system for clinical care at primary care centers.
- Individuals who are able and willing to provide informed consent for participation in the study.
Exclusion
Key Trial Info
Start Date :
July 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06882356
Start Date
July 16 2025
End Date
September 1 2030
Last Update
August 28 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Primary Care Associates of Longwood
Boston, Massachusetts, United States, 02115
2
MGH Chelsea HealthCare Center
Chelsea, Massachusetts, United States, 02150
3
NSPG Lynn
Lynn, Massachusetts, United States, 01904
4
NSPG Salem
Salem, Massachusetts, United States, 01970